Bendamustine Hydrochloride 60505-6228
Product NDC
60505-6228- Manufacturer
- Apotex Corp
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- April 26, 2023
- Listing Expires
- December 31, 2026
- Application
- NDA215033
Need to source Bendamustine Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bendamustine Hydrochloride | 25 mg/mL |
Drug Class
Alkylating Activity [MoA]Alkylating Drug [EPC]
Packaging Options(1)
1 VIAL, MULTI-DOSE in 1 CARTON (60505-6228-0) / 5 mL in 1 VIAL, MULTI-DOSE